| 前收盘价格 | 63.21 |
| 收盘价格 | 63.35 |
| 成交量 | 2,224,424 |
| 平均成交量 (3个月) | 2,421,864 |
| 市值 | 14,224,081,920 |
| 市盈率 (P/E TTM) | 20.06 |
| 预期市盈率 (P/E Forward) | 15.17 |
| 价格/销量 (P/S) | 3.75 |
| 股市价格/股市净资产 (P/B) | 3.04 |
| 52周波幅 | |
| 利润日期 | 30 Apr 2025 - 5 May 2025 |
| 营业毛利率 | 18.42% |
| 营业利益率 (TTM) | 22.87% |
| 稀释每股收益 (EPS TTM) | 3.16 |
| 季度收入增长率 (YOY) | 0.90% |
| 季度盈利增长率 (YOY) | -18.50% |
| 总债务/股东权益 (D/E MRQ) | 53.22% |
| 流动比率 (MRQ) | 3.48 |
| 营业现金流 (OCF TTM) | 1.25 B |
| 杠杆自由现金流 (LFCF TTM) | 902.83 M |
| 资产报酬率 (ROA TTM) | 7.10% |
| 股东权益报酬率 (ROE TTM) | 15.78% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | Hologic, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
1.7
| 分析师共识 | 3.0 |
| 内部交易活动 | 3.0 |
| 价格波动 | 5.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.70 |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 1.13% |
| 机构持股比例 | 104.90% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 90.00 (Raymond James, 41.98%) | 购买 |
| 90.00 (Needham, 41.98%) | 保留 | |
| 中 | 83.00 (30.94%) | |
| 低 | 70.00 (Citigroup, 10.43%) | 保留 |
| 平均值 | 81.13 (27.99%) | |
| 总计 | 2 购买, 6 保留 | |
| 平均价格@调整类型 | 66.45 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 04 Mar 2025 | 70.00 (10.43%) | 保留 | 62.30 |
| Evercore ISI Group | 06 Feb 2025 | 73.00 (15.16%) | 保留 | 65.45 |
| Leerink Partners | 06 Feb 2025 | 75.00 (18.32%) | 保留 | 65.45 |
| RBC Capital | 06 Feb 2025 | 85.00 (34.09%) | 保留 | 65.45 |
| Raymond James | 06 Feb 2025 | 90.00 (41.98%) | 购买 | 65.45 |
| Stephens & Co. | 06 Feb 2025 | 84.00 (32.51%) | 购买 | 65.45 |
| Needham | 03 Feb 2025 | 90.00 (41.98%) | 保留 | 71.72 |
| 13 Jan 2025 | 90.00 (41.98%) | 购买 | 70.29 | |
| Morgan Stanley | 13 Jan 2025 | 82.00 (29.36%) | 保留 | 70.29 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合